Thank you sir.

Just published! MASCC Antiemetic Consensus Recommendations: Resource-Limited Settings link.springer.com/article/10.100… #SuppOnc #GlobOnc OncoAlert Supportive Care in Cancer: Springer Journal Dr Snezana Bosnjak Ana Zilic Prof Vikas Ostwal

MASCC OncoAlert Supportive Care in Cancer: Springer Journal Ana Zilic Prof Vikas Ostwal Grateful to MASCC for recognizing the access-to-antiemetic issue and the need to tailor guidelines for resource limited settings & define alternative regimens when NK1-RAs are not accessible. #CancerCare medicines are not just for cancer #AccessToMedicines #SuppOnc

MASCC OncoAlert Supportive Care in Cancer: Springer Journal Dr Snezana Bosnjak Prof Vikas Ostwal Thank you MASCC for recognizing that there is a need to tailor antiemetic treatment in resource-limited settings. The goal is to support and care even in the challenging settings.

Tomorrow is #InternationalChildhoodCancerDay! Watch our🆕videos on the ChildGICR Masterclass, including short chats with creators, trainers, & participants. ChildGICR=Targeting #ChildhoodCancer through the Global Initiative for #Cancer Registry Development iarc.who.int/news-events/ia…

Most cases of #cancer in children occur in low- and middle-income countries. See how IARC & partners are working to transform paediatric cancer registration worldwide, in support of the World Health Organization (WHO) Global Initiative for #ChildhoodCancer. youtu.be/GRAkxcmpHro

link.springer.com/article/10.100… Risk adapted strategy in #Wilms #tumor works. NWTS for early staging avoiding over treatment with Adriamycin. SIOP for advanced stages avoiding tumor spill and consequent radiation. 5 year OS >90% for the entire cohort.

Childhood cancer survival rates are below 30% in resource-limited countries, partly due to underdiagnosis and lack of reliable data. A new registry created by St. Jude Global Scholar Venkatraman Radhakrishnan, MD, is addressing this gap in Chennai, India.

Cancer registries are vital for understanding pediatric cancer’s impact. With support from St. Jude, Chennai’s first population-based childhood cancer registry is transforming care with accurate data collection and analysis. Learn more: ow.ly/vezl50VFnQW

Out now The Lancet Reg Health-Southeast Asia Pre-trial 2013-18 run-in cohort for #ICiCLe2014- 🇮🇳 largest multicenter prospectve trial enrolled 2695 children with ALL, 6 centers, ~50% from Tata Memorial Hospital incorporated risk-stratification & response-adaption sciencedirect.com/science/articl…

The Lancet Reg Health-Southeast Asia Tata Memorial Hospital PHO INDIA INPHOG SIOP International OncoDaily SIOP Asia Prashant Tembhare Pediatric Hematology Oncology Journal Young SIOP Children’s Oncology Group ALL Hub Proved: - Together we can! - Standardized MRD & Genetics across 🇮🇳 - Improved outcomes significantly over historical data - Launchpad for #ICiCLe2014 RCT from 2018-22 - Center-wise variability a concern - Improvements in RCT $ ISCALL ICMR Venky Prashant Tembhare

Congratulations to the team. Landmark trial show casing excellent multi-centre collaborative effort.

Bone tumors, seen commonly in children and adolescents are curable if diagnosed early! Young SIOP SIOP International Aditya Gupta AIIMS, New Delhi 🇮🇳 Debabrata Mohapatra Venky

When neuroblastoma hugs the renal vessels too tight, the kidney may silently vanish. Our new paper dissects the hidden risk of autonephrectomy. Read here 👉 rdcu.be/emu95 #Neuroblastoma #PedsSurgery #OncoTwitter #MedTwitter Cancer Institute (WIA), Chennai Venky

Tumor thrombus in osteosarcoma—rare, aggressive, and under-recognized. Our latest paper explores major vascular tumor thrombi in extremity osteosarcoma, revealing the challenges in diagnosis and the critical need for surgical preparedness. 🩸 Tumor thrombus ≠ bland thrombus.

📊 Who’s on the podium at #ASCO? Audit of 1563 oral presentations (2021–24) reveals: 🇺🇸 USA – 66.7% 🇨🇳 China – 6.3% 🇫🇷 France – 4.0% 🇬🇧 UK – 3.2% 🇨🇦 Canada – 2.3% 🇯🇵 Japan – 1.8% 🇩🇪 Germany – 1.4% 🇰🇷 South Korea – 0.8% 🌍 Africa – 0% 🌎 South America – 0.3% 🌏 Middle East – 0.1%

Cancer Institute (W.I.A) Adyar Chennai. youtube.com/watch?v=sPJc1N…

#ASCO25 #ASCO2025 Tips for the meeting from a resource limited perspective. Continues to be relevant 2 years later.

Very educative interaction with Balazs Halmos on immunotherapy in lung cancer with Cancer Institute (W.I.A) Medical Oncology senior residents and faculty.

Importance of research in cancer care. #Oncology #research #cancer